TWO SIGMA ADVISERS, LP - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 120 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$4,244,000
-23.2%
106,100
-15.7%
0.01%
-30.8%
Q1 2024$5,528,269
-29.8%
125,900
-1.2%
0.01%
-27.8%
Q4 2023$7,879,690
+100.6%
127,400
+49.2%
0.02%
+80.0%
Q3 2023$3,927,546
-5.9%
85,400
+17.6%
0.01%
-9.1%
Q2 2023$4,172,322
+88.3%
72,600
+22.8%
0.01%
+83.3%
Q1 2023$2,216,250
-1.6%
59,100
-26.5%
0.01%0.0%
Q4 2022$2,252,808
-11.5%
80,400
-11.3%
0.01%
-14.3%
Q3 2022$2,546,000
-34.3%
90,600
-18.7%
0.01%
-36.4%
Q2 2022$3,876,000
+355.5%
111,400
+370.0%
0.01%
+450.0%
Q1 2022$851,000
+108.6%
23,700
+35.4%
0.00%
+100.0%
Q4 2021$408,000
+29.1%
17,500
+5.4%
0.00%0.0%
Q3 2021$316,000
-10.0%
16,600
-4.6%
0.00%0.0%
Q2 2021$351,000
-50.4%
17,400
-54.9%
0.00%
-50.0%
Q1 2021$707,000
-15.3%
38,600
-7.0%
0.00%0.0%
Q4 2020$835,000
-71.7%
41,500
-73.6%
0.00%
-75.0%
Q3 2020$2,946,000
+566.5%
157,100
+604.5%
0.01%
+700.0%
Q3 2019$442,000
-40.0%
22,300
-36.1%
0.00%
-50.0%
Q2 2019$737,000
+45.9%
34,900
+41.3%
0.00%
+100.0%
Q1 2019$505,000
+83.6%
24,700
+79.0%
0.00%0.0%
Q4 2018$275,000
+20.1%
13,800
+13.1%
0.00%0.0%
Q1 2018$229,000
+24.5%
12,200
+18.4%
0.00%0.0%
Q3 2017$184,000
-22.7%
10,300
-22.6%
0.00%0.0%
Q2 2017$238,000
-73.0%
13,300
-78.1%
0.00%
-66.7%
Q1 2017$880,000
-45.8%
60,700
-31.2%
0.00%
-50.0%
Q4 2016$1,625,000
-17.3%
88,200
-14.9%
0.01%
-25.0%
Q3 2016$1,965,000
+4.5%
103,600
-11.2%
0.01%
-20.0%
Q2 2016$1,881,000
+28.5%
116,700
-4.3%
0.01%
+25.0%
Q1 2016$1,464,000
-13.1%
122,000
+3.0%
0.01%
-20.0%
Q4 2015$1,685,000
+12.7%
118,438
-6.2%
0.01%
+11.1%
Q3 2015$1,495,000
-51.3%
126,302
-27.7%
0.01%
-62.5%
Q2 2015$3,071,000
+718.9%
174,701
+596.0%
0.02%
+700.0%
Q1 2015$375,00025,1000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Summit Global Investments 58,640$870,0000.13%
FEDERATED HERMES, INC. 2,600,120$38,586,0000.11%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 284,328$4,219,0000.07%
SILVERCREST ASSET MANAGEMENT GROUP LLC 291,352$4,324,0000.05%
MARSHALL WACE, LLP 301,910$4,481,0000.04%
MARTINGALE ASSET MANAGEMENT L P 212,817$3,159,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 171,266$2,542,0000.03%
WINTON GROUP Ltd 82,402$1,223,0000.03%
EAGLE ASSET MANAGEMENT INC 317,988$4,718,0000.03%
Engineers Gate Manager LP 24,007$356,0000.03%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders